Health ❯ Chronic Diseases ❯ Diabetes

Obesity

Hypertension Treatment Options Weight Management Dementia Cardiovascular Diseases Dietary Interventions GLP-1 Receptor Agonists Public Health Implications Smoking Sarcopenia GLP-1 Medications GLP-1 Market Semaglutide-Based Therapies Neurodevelopmental Disorders Cardiometabolic Benefits Breast Cancer Medication Development Health Outcomes Inflammation GLP-1 Agonists Treatment Protocols Drug Treatments Dietary Impact Kidney Transplants Lifestyle Factors Cancer Prevention Sedentary Lifestyle Health Risks Cancer Treatment Innovations Impact of Meal Timing Cardiovascular Risk Risk Factors Heart Failure GLP-1 Treatments Artificial Sweeteners Dietary Changes Healthcare Access Medication Effects Weight Loss Drugs

Semaglutide Extends Lifespan and Slows Ageing in Older Female Mice

An NIH-funded Nature paper shows semaglutide mimics calorie-restriction molecular signatures, improves key functions including memory and blood-sugar control, prompting calls for human trials to assess safety and benefit.

Higher Blood Xylitol Levels Linked to Increased Risk of Heart Attack, Stroke and Death

Lab Study Finds Many Sweeteners Alter Gut Bacteria

Eli Lilly Spends $3.8 Billion to Build Vaccine Business

RSNA Study Links Muscle Mass, Lower Visceral Fat to Younger 'Brain Age'

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study